KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) EBT Margin (2016 - 2025)

Historic EBT Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 2.5%.

  • Biolife Solutions' EBT Margin rose 50800.0% to 2.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.55%, marking a year-over-year decrease of 214300.0%. This contributed to the annual value of 13.89% for FY2024, which is 104600.0% up from last year.
  • Per Biolife Solutions' latest filing, its EBT Margin stood at 2.5% for Q3 2025, which was up 50800.0% from 61.81% recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' EBT Margin peaked at 2.5% during Q3 2025, and registered a low of 219.83% during Q4 2022.
  • Its 5-year average for EBT Margin is 50.96%, with a median of 22.14% in 2022.
  • Per our database at Business Quant, Biolife Solutions' EBT Margin plummeted by -1900600bps in 2021 and then skyrocketed by 1757700bps in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' EBT Margin stood at 49.12% in 2021, then crashed by -348bps to 219.83% in 2022, then rose by 16bps to 185.16% in 2023, then surged by 95bps to 9.39% in 2024, then surged by 127bps to 2.5% in 2025.
  • Its EBT Margin stands at 2.5% for Q3 2025, versus 61.81% for Q2 2025 and 1.81% for Q1 2025.